NO882256L - Fremgangsmaate for fremstilling av farmakologisk aktive kinolinforbindelser. - Google Patents

Fremgangsmaate for fremstilling av farmakologisk aktive kinolinforbindelser.

Info

Publication number
NO882256L
NO882256L NO882256A NO882256A NO882256L NO 882256 L NO882256 L NO 882256L NO 882256 A NO882256 A NO 882256A NO 882256 A NO882256 A NO 882256A NO 882256 L NO882256 L NO 882256L
Authority
NO
Norway
Prior art keywords
procedure
preparation
pharmacologically active
quinol compounds
quinol
Prior art date
Application number
NO882256A
Other languages
English (en)
Other versions
NO882256D0 (no
Inventor
Yukihiko Kinoshita
Yukiyoshi Ajisawa
Seiichi Ikeguchi
Arao Ujiie
Naoyuki Tsutsumi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12867387A external-priority patent/JPH0745404B2/ja
Priority claimed from JP12867287A external-priority patent/JPH0796552B2/ja
Priority claimed from JP13294687A external-priority patent/JPH0684303B2/ja
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO882256D0 publication Critical patent/NO882256D0/no
Publication of NO882256L publication Critical patent/NO882256L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO882256A 1987-05-26 1988-05-24 Fremgangsmaate for fremstilling av farmakologisk aktive kinolinforbindelser. NO882256L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12867387A JPH0745404B2 (ja) 1987-05-26 1987-05-26 骨粗鬆症治療剤
JP12867287A JPH0796552B2 (ja) 1987-05-26 1987-05-26 ベンゾフロ〔3,2−c〕キノリン誘導体
JP13294687A JPH0684303B2 (ja) 1987-05-28 1987-05-28 骨粗鬆症治療剤

Publications (2)

Publication Number Publication Date
NO882256D0 NO882256D0 (no) 1988-05-24
NO882256L true NO882256L (no) 1988-11-28

Family

ID=27315793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882256A NO882256L (no) 1987-05-26 1988-05-24 Fremgangsmaate for fremstilling av farmakologisk aktive kinolinforbindelser.

Country Status (6)

Country Link
EP (1) EP0293146A1 (no)
KR (1) KR880013896A (no)
AU (1) AU615907B2 (no)
DK (1) DK284388A (no)
FI (1) FI882465A7 (no)
NO (1) NO882256L (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK224589A (da) * 1988-05-09 1989-11-10 Merck & Co Inc Polymalonsyreforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
JPH0692410B2 (ja) * 1988-08-30 1994-11-16 キッセイ薬品工業株式会社 新規なベンゾフロキノリン誘導体
EP0370760A3 (en) * 1988-11-22 1991-07-24 Kissei Pharmaceutical Co., Ltd. Benzofuro[3,2-c]quinoline compounds
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
CN113717185B (zh) * 2021-08-19 2023-04-11 云南省烟草农业科学研究院 雪茄烟根茎中一种具有抗菌活性的喹啉生物碱化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6048924A (ja) * 1983-08-24 1985-03-16 Takeda Chem Ind Ltd 骨粗鬆症治療剤

Also Published As

Publication number Publication date
FI882465A0 (fi) 1988-05-25
FI882465A7 (fi) 1988-11-27
DK284388A (da) 1988-11-27
DK284388D0 (da) 1988-05-25
KR880013896A (ko) 1988-12-22
AU1667088A (en) 1988-12-01
AU615907B2 (en) 1991-10-17
EP0293146A1 (en) 1988-11-30
NO882256D0 (no) 1988-05-24

Similar Documents

Publication Publication Date Title
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO159166C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater.
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO157503C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive azepinderivater.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO881762D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO880910D0 (no) Fremgangsmaate for fremstilling av chromonderivater.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO167668C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive epipodofyllotoksinglukosid-4'-acylderivater.
NO882256D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive kinolinforbindelser.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO880922D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzodioksolderivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO884100L (no) Fremgangsmaate for fremstilling av halogentiazolderivater.
NO883398D0 (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO169337C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme nafthalenderivater.